1. Nattel S, Shiroshita-Takeshita A, Brundel BJ, et al. Mechanisms of atrial fibrillation: lessons from animal models. Prog Cardiovasc Dis. Jul-Aug 2005;48(l):9-28.

2. Bayes de Luna A, Fort de Ribot R, Trilla E, et al. Electrocardiographic and vectorcardiographic study of interatrial conduction disturbances with left atrial retrograde activation. J Electrocardiol. 1985;18(1):1-13.

3. Ariyarajah V, Spodick DH. Advanced interatrial block: a classic electrocardiogram. Cardiology. 2005; 104(1):33-34.

4. Ariyarajah V, Puri P, Spodick DH. Clinician underappreciation of interatrial block in a general hospital population. Cardiology. 2005;104(4): 193-195.

5. Platonov P, Carlson J, Ingemansson M, et al. Detection of concealed interatrial conduction delay from morphology of the signal-averaged P-wave. Eur Heart J. 1998; 19 [Abstr. Suppl.] :666.

6. Papageorgiou P, Monahan K, Boyle NG, et al. Site-de- pendent intra-atrial conduction delay. Relationship to initiation of atrial fibrillation. Circulation. 1996;94(3):384-389.

7. Platonov PG, Yuan S, Hertervig E, et al. Further evidence of localized posterior interatrial conduction delay in lone paroxysmal atrial fibrillation. Europace. Apr2001;3(2): 100-107.

8. Xia Y, Hertervig E, Kongstad 0, et al. Deterioration of interatrial conduction in patients with paroxysmal atrial fibrillation: electroanatomic mapping of the right atrium and coronary sinus. Heart Rhythm. Nov 2004; 1(5):548-553.

9. Bachmann G. The inter-auricular time interval. Am J Physiol. 1916;41:309-320.

10. Hayashi H, Lux RL, Wyatt RF, et al. Relation of canine atrial activation sequence to anatomic landmarks. Am J Physiol. 1982;242(3):H421-428.

11. Duytschaever M, Danse P, Eysbouts S, et al. Is there an optimal pacing site to prevent atrial fibrillation?: an experimental study in the chronically instrumented goat. J Cardio- vasc Electrophysiol. Dec 2002; 13(12): 1264-1271.

12. Roithinger FX, Cheng J, SippensGroenewegen A, et al. Use o f Electroanatomic Mapping to Delineate Transseptal Atrial Conduction in Humans. Circulation. 1999;100(17):1791-1797.

13. Ho SY, Sanchez-Quintana D, Cabrera JA, et al. Anatomy of the left atrium: implications for radiofrequency ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 1999;10(11):1525-1533.

14. Platonov PG, Mitrofanova LB, Chireikin LV, et al. Morphology of inter-atrial conduction routes in patients with atrial fibrillation. Europace. Apr 2002;4(2): 183-192.

15. Kozlowski D, Kaminski R, Piwko G, et al. Preliminary study of external interatrial muscle fascicles. Folia Morphol (Warsz). 2002;61(2):97-101.

16. Chauvin M, Shah D, Haissaguerre M, et al. The anatomic basis of connections between the coronary sinus musculature and the left atrium in humans. Circulation. February 15,2000 2000;101(6):647-652.

17. Mitrofanova L, Ivanov V, Platonov PG. Anatomy ofthe inferior interatrial route in humans. Europace. Sep 2005 ;7 Suppl 2:49-55.

18. Markides V, Schilling RJ, Ho SY, et al. Characterization of left atrial activation in the intact human heart. Circulation. Feb 112003; 107(5):733-739.

19. Lemery R, Soucie L, Martin B, et al. Human study of biatrial electrical coupling: determinants of endocardial septal activation and conduction over interatrial connections. Circulation. Oct 12 2004; 110(15):2083-2089.

20. Frustaci A, Caldarulo M, Buffon A, et al. Cardiac biopsy in patients with “primary” atrial fibrillation. Histologic evidence ofoccultmyocardialdiseases.Chest. 1991;100(2):303-306.

21. Frustaci A, Chimenti C, Bellocci F, et al. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation. 1997;96(4):1180-1184.

22. Becker AE. How structurally normal are human atria in patients with atrial fibrillation? Heart Rhythm. Nov 2004; 1(5):627-631.

23. Everett TH, IV, Li H, Mangrum JM, et al. Electrical, morphological, and ultrastructural remodeling and reverse remodeling in a canine model of chronic atrial fibrillation. Circulation. September 19,2000 2000; 102(12): 1454-1460.

24. Li D, Fareh S, Leung TK, et al. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation. Jul 6 1999;100(l):87-95.

25. Li D, Shinagawa K, Pang L, et al. Effects of angiotensinconverting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypac- ing-induced congestive heart failure. Circulation. Nov 20 2001;104(21):2608-2614.

26. Celik T, Iyisoy A, Kursaklioglu H, et al. The comparative effects of telmisartan and ramipril on P-wave dispersion in hypertensive patients: a randomized clinical study. Clin Cardiol. Jun 2005;28(6):298-302.

27. Fuenmayor AJ, Moreno G, Landaeta A, et al. Inter-atrial conduction time shortens after blood pressure control in hypertensive patients with left ventricular hypertrophy. Int J Cardiol. Jul 20 2005; 102(3):443-446.

28. Madrid AH, Bueno MG, Rebollo JM, et al. Use of irbe- sartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study. Circulation. Jul 16 2002; 106(3):331-336.

29. Ueng КС, Tsai TP, Yu WC, et al. Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled study. Eur Heart J. Dec 2003;24(23):2090-2098.

30. Saksena S, Prakash A, Hill M, et al. Prevention of recurrent atrial fibrillation with chronic dual-site right atrial pacing. J Am Coll Cardiol. 1996;28(3):687-694.

31. Lau C, Tse H, Yu C, et al. Dual-site atrial pacing for atrial fibrillation in patients without bradycardia. Am J Cardiol. 2001;88(4):371-375.

32. Padeletti L, Porciani MC, Michelucci A, et al. Interatrial septum pacing: a new approach to prevent paroxysmal atrial fibrillation. Pacing Clin Electrophysiol. 1998;21 [Pt.II]:797. 33. Saksena S, Delfaut P, Prakash A, et al. Multisite electrode pacing for prevention of atrial fibrillation. J Cardio- vasc Electrophysiol. Aug 1998;9(8 Suppl):S155-162.

33. Fitts SM, Hill MR, Mehra R, et al. Design and implementation of the Dual Site Atrial Pacing to Prevent Atrial Fibrillation (DAPPAF) clinical trial. DAPPAF Phase I Investigators. JInterv Card Electrophysiol. Jun 1998;2(2): 139-144.

34. AAC/AHA/ESCguidelinesforthemanagementofpatients with atrial fibrillation. Eur Heart J. 2001;22:1852-1923.